☐
Fax completed prior authorization request form to 800-854-7614 or submit Electronic Prior Authorization through
CoverMyMeds® or SureScripts.
Al
l requested data must be provided. Incomplete forms or forms without the chart notes will be returned
Pharmacy Coverage Guidelines are available at www.
mercycareaz.org/providers/completecare-
forproviders/pharmacy
Idiopathic Pulmonary Fibrosis
Pharmacy Prior Authorization Request Form
Do not copy for future use. Forms are updated frequently.
REQUIRED: Office notes, labs an
d medical testing relevant to request showing medical justification are required to support diagnosis
Member Name (first & last):
Male Female
Member ID: City: State: Weight:
Prescribing Provider Information
Provider Name (first & last): Specialty: NPI# DEA#
Office Address: City: State: Zip Code:
Dispensing Pharmacy Information
Requested Medication Information
Esbriet
Ofev
Other, please specify:
What medication(s) has member tried and failed for this diagnosis?
Are there any contraindications to formulary medications? Yes No
If yes, please specify:
New
request
Continuation
request
Medication request is NOT for an FDA approved, or
compendia supported diagnosis (circle one):
Yes No
Diagnosis: ICD-10 Code:
Directions
for Use: Strength: Dosage Form:
Quantity: Day Supply: Duration of Therapy/Use:
Turn-Around Time for Review
Urgent – waiting 24 hours for a standard decision could seriously harm life,
health, or ability to regain maximum function, you can ask for an expedited
decision.
Signature:
_____________________________________________________
Is FVC
40% predicted? Yes No Is Carbon Monoxide Diffusion Capacity
≥30%
Yes No
Were baseline LFTs completed?
Is member a current smoker?
Have other known causes of interstitial lung disease been ruled out?
(for example, domestic AND occupational environmental exposures, connective tissue disease OR drug toxicity)
Is member a female of
reproductive potential?
Did the female member have
a NEGATIVE pregnancy test?
☐ Idiopathic Pulmonary Fibrosis
Effective: 06/28/2021 C7837-A 01-2021 Page 1 of 2
click to sign
signature
click to edit